BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Celeris Therapeutics

Celeris Therapeutics logo



AI Companies (Drug Discovery) Protein Degraders Startups

Celeris Therapeutics is going to solve the R&D shortcomings as the pioneer in AI-driven PIC (proximity-inducing compounds) design using an innovative closed-loop engine (Celeris One™ platform) to develop new chemical entities (NCEs) that degrade proteins by establishing proximity to endogenous cellular mechanisms. The solutions include machine learning-driven prediction of interactions, generative design, optimization of molecular properties, and automation of laboratory devices.

Become a Member to view additional information about this company

Posts Mentioning This Company

BiopharmaTrend Blog
New Tools, Products and Technologies